Nitric oxide accelerates the degradation of tetrahydrobiopterin but not total neopterin in cerebrospinal fluid; potential implications for the assessment of tetrahydrobiopterin metabolism.
Assessment of total neopterin and tetrahydrobioterin (BH4) concentrations in cerebrospinal fluid (CSF) can be used to identify potential disorders of BH4 biosynthesis. In this study, we demonstrate that exposure of CSF to nitric oxide leads to an accelerated degradation of BH4 but does not affect the total neopterin concentration. These data suggest that in those conditions associated with increased nitric oxide formation, perturbation of the total neopterin to BH4 ratio could occur. Under such circumstances a putative diagnosis of a defect in BH4 biosynthesis may erroneously be proposed. Assessment of central nitric oxide generation may therefore be a useful adjunct to the determination of CSF pterin status.
Lam
A A J
AA
Neurometabolic Unit, National Hospital, Queen Square & Department of Molecular Neuroscience Institute of Neurology (UCL), Queen Square, London, UK.
Heales
S J R
SJ
D001708:Biopterins / Q000031:analogs & derivatives* / Q000378:metabolism; D002555:Cerebrospinal Fluid / Q000187:drug effects* / Q000378:metabolism; D006801:Humans; D019798:Neopterin / Q000378:metabolism*; D009569:Nitric Oxide / Q000494:pharmacology*
D001708:Biopterins; D009569:Nitric Oxide; D019798:Neopterin; C003402:sapropterin